0001766784-23-000002.txt : 20231109 0001766784-23-000002.hdr.sgml : 20231109 20231109134035 ACCESSION NUMBER: 0001766784-23-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231109 DATE AS OF CHANGE: 20231109 EFFECTIVENESS DATE: 20231109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mediar Therapeutics, Inc. CENTRAL INDEX KEY: 0001766784 IRS NUMBER: 832874878 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-466474 FILM NUMBER: 231391614 BUSINESS ADDRESS: STREET 1: 20 OVERLAND STREET STREET 2: SUITE 520 CITY: BOSTON STATE: MA ZIP: 02215 BUSINESS PHONE: 617-954-9356 MAIL ADDRESS: STREET 1: 20 OVERLAND STREET STREET 2: SUITE 520 CITY: BOSTON STATE: MA ZIP: 02215 D/A 1 primary_doc.xml X0708 D/A LIVE 0001766784 Mediar Therapeutics, Inc. 20 Overland Street Suite 520 Boston MA MASSACHUSETTS 02215 617-954-9356 DELAWARE None None Corporation true 2018 Rahul Ballal c/o Mediar Therapeutics, Inc. 20 Overland Street, Suite 520 Boston MA MASSACHUSETTS 02215 Executive Officer Director Peter Parker c/o Mediar Therapeutics, Inc. 20 Overland Street, Suite 520 Boston MA MASSACHUSETTS 02215 Director Michael Baran c/o Mediar Therapeutics, Inc. 20 Overland Street, Suite 520 Boston MA MASSACHUSETTS 02215 Director Meredith Fisher c/o Mediar Therapeutics, Inc. 20 Overland Street, Suite 520 Boston MA MASSACHUSETTS 02215 Director Maina Bhaman c/o Mediar Therapeutics, Inc. 20 Overland Street, Suite 520 Boston MA MASSACHUSETTS 02215 Director Andreas Jurgeit c/o Mediar Therapeutics, Inc. 20 Overland Street, Suite 520 Boston MA MASSACHUSETTS 02215 Director Anja Konig c/o Mediar Therapeutics, Inc. 20 Overland Street, Suite 520 Boston MA MASSACHUSETTS 02215 Director Biotechnology Decline to Disclose 06b true 0001766784-22-000002 2022-11-18 true true false 0 85034867 60602620 24432247 false 17 0 0 0 false Mediar Therapeutics, Inc. /s/ Rahul Ballal Rahul Ballal Chief Executive Officer 2023-11-09